Related references
Note: Only part of the references are listed.Annexin A1 attenuates neuroinflammation through FPR2/p38/COX-2 pathway after intracerebral hemorrhage in male mice
Yan Ding et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling
Pim J. Koelink et al.
GUT (2020)
Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies
Jay Luther et al.
INFLAMMATORY BOWEL DISEASES (2020)
The epidemiology of inflammatory bowel disease: East meets west
Wing Yan Mak et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia
Marina Gomes Machado et al.
FASEB JOURNAL (2020)
Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease*
Akter Hossain et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
Annexin A1 Expression Capacity as a Determinant for Disease Severity in Crohn's Disease
Stefan Reischl et al.
DIGESTIVE DISEASES (2020)
Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing
Gwo-tzer Ho et al.
INFLAMMATORY BOWEL DISEASES (2020)
Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation
Ronald Neil Kostoff et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction
Yulin Huang et al.
INFLAMMATION (2020)
Mesenchymal stem cell-derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway
Xiaohe Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
Robert L. Keith et al.
CANCER PREVENTION RESEARCH (2019)
Regulation of endothelial cell survival and death by the MAP kinase/ERK kinase kinase 3-glyceraldehyde-3-phosphate dehydrogenase signaling axis
Yong Q. Li et al.
CELLULAR SIGNALLING (2019)
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Yi Rang Na et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Control of expression and activity of peroxisome proliferated-activated receptor γ by Annexin A1 on microglia during efferocytosis
Gustavo Henrique Oliveira da Rocha et al.
CELL BIOCHEMISTRY AND FUNCTION (2019)
A Practical Guide to the Safety and Monitoring of New IBD Therapies
Benjamin Click et al.
INFLAMMATORY BOWEL DISEASES (2019)
Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand
Bunchai Chongmelaxme et al.
PHARMACOECONOMICS (2019)
Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity
Nathalia T. Pietrani et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats
Jessica Mendes Bonato et al.
EXPERIMENTAL NEUROLOGY (2018)
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
Stephanie Da Silva et al.
INFLAMMATORY BOWEL DISEASES (2018)
Annexin A1: Uncovering the Many Talents of an Old Protein
Madeeha H. Sheikh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Changing treatment paradigms for the management of inflammatory bowel disease
Jong Pil Im et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease — United States, 2015 and 2016
Fang Xu et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
ERK Signaling Controls Innate-like CD8+ T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors
Diane Maurice et al.
JOURNAL OF IMMUNOLOGY (2018)
Pioglitazone for the treatment of Alzheimer's disease
Daniela Galimberti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases
Luiza Oliveira Perucci et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling
Miguel Quiros et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
P110 Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease
D. Bernardo et al.
Journal of Crohns & Colitis (2017)
PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
Luxi Chen et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Analysis of murine and human Treg subsets in inflammatory bowel disease
Xiaoyun Sun et al.
MOLECULAR MEDICINE REPORTS (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice
Anh Do et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
The ANXA1 released from intestinal epithelial cells alleviate DSS-induced colitis by improving NKG2A expression of Natural Killer cells
Z. Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Role of the protein annexin A1 on the efficacy of anti-TNF treatment in a murine model of acute colitis
Marina de Paula-Silva et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1
Juliana P. Vago et al.
JOURNAL OF IMMUNOLOGY (2016)
Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-γ pathway
Labanyamoy Kole et al.
PHARMACOLOGICAL REPORTS (2016)
Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance
Michelle Amantea Sugimoto et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression
Liang-qi Cao et al.
CANCER LETTERS (2015)
Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD
Donata Lissner et al.
INFLAMMATORY BOWEL DISEASES (2015)
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
Giovanna Leoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis
L. Wang et al.
MUCOSAL IMMUNOLOGY (2015)
Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia
Xiaotan Dou et al.
ONCOLOGY LETTERS (2015)
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
Derek C. Marshall et al.
PLOS ONE (2015)
Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma
Z. Boudhraa et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling
Kai Hong et al.
IMMUNOLOGY LETTERS (2014)
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Erin C. Steinbach et al.
INFLAMMATORY BOWEL DISEASES (2014)
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
Augusta Pisanu et al.
NEUROBIOLOGY OF DISEASE (2014)
Absence of Intestinal PPARc Aggravates Acute Infectious Colitis in Mice through a Lipocalin-2-Dependent Pathway
Parag Kundu et al.
PLOS PATHOGENS (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease
Angela Sena et al.
PLOS ONE (2013)
Role of an Indole-Thiazolidine Molecule PPAR Pan-Agonist and COX Inhibitor on Inflammation and Microcirculatory Damage in Acute Gastric Lesions
Jose Roberto Santin et al.
PLOS ONE (2013)
The impact of endogenous annexin A1 on glucocorticoid control of in ammatory arthritis
Hetal B. Patel et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Annexin A1 Interaction with the FPR2/ALX Receptor IDENTIFICATION OF DISTINCT DOMAINS AND DOWNSTREAM ASSOCIATED SIGNALING
Stefania Bena et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks
Martina Perse et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis
Juliana P. Vago et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Up-Regulation of Annexin-A1 and Lipoxin A4 in Individuals with Ulcerative Colitis May Promote Mucosal Homeostasis
Linda Vong et al.
PLOS ONE (2012)
MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis
Nengtai Ouyang et al.
PLOS ONE (2012)
Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2
Hao Wang et al.
BIOSCIENCE TRENDS (2012)
Peroxisome Proliferator-activated Receptorgamma (PPAR-γ) Expression is Downregulated in Patients with Active Ulcerative Colitis
Jesus K. Yamamoto-Furusho et al.
INFLAMMATORY BOWEL DISEASES (2011)
Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease
R. Hontecillas et al.
MUCOSAL IMMUNOLOGY (2011)
Mouse and human intestinal immunity: same ballpark, different players; different rules, same score
D. L. Gibbons et al.
MUCOSAL IMMUNOLOGY (2011)
PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease
Ruby Fernandez-Boyanapalli et al.
BLOOD (2010)
A Proinflammatory Role for Proteolytically Cleaved Annexin A1 in Neutrophil Transendothelial Migration
Samantha L. Williams et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
Neil Dufton et al.
JOURNAL OF IMMUNOLOGY (2010)
Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction
Rogelio Zamilpa et al.
PROTEOMICS (2010)
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ LIGANDS 15-DEOXY-δ12,14-PROSTAGLANDIN J2 AND PIOGLITAZONE INHIBIT HYDROXYL PEROXIDE-INDUCED TNF-α AND LIPOPOLYSACCHARIDE-INDUCED CXC CHEMOKINE EXPRESSION IN NEONATAL RAT CARDIAC MYOCYTES
Jingwei Liu et al.
SHOCK (2009)
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Mauro Perretti et al.
NATURE REVIEWS IMMUNOLOGY (2009)
PIOGLITAZONE INHIBITS HOMOCYSTEINE-INDUCED MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS THROUGH A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ-INDEPENDENT MECHANISM
Li Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Rosiglitazone for active ulcerative colitis: A randomized placebo-controlled trial
James D. Lewis et al.
GASTROENTEROLOGY (2008)
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease
Silvia Melgar et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair
Brian A. Babbin et al.
JOURNAL OF IMMUNOLOGY (2008)
A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis
Hong-Liang Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Annexin 1 cleavage in activated neutrophils - A pivotal role for proteinase 3
Linda Vong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differential expression, distribution, and function of PPAR-γ in the proximal and distal colon
Weidong Su et al.
PHYSIOLOGICAL GENOMICS (2007)
Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitis
Yatrik M. Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
PPAR-γ expression in pituitary tumours and the functional activity of the glitazones:: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-γ receptor
Michelle N. Emery et al.
CLINICAL ENDOCRINOLOGY (2006)
Attenuation of experimental colonic injury by thiazolidinedione agents
K Takaki et al.
INFLAMMATION RESEARCH (2006)
Linkage to peroxisome proliferator-activated receptor-γ in SAMP1/YitFc mice and in human Crohn's disease
K Sugawara et al.
GASTROENTEROLOGY (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis
LJ Saubermann et al.
INFLAMMATORY BOWEL DISEASES (2002)
Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappa B-cytokine cascade
T Takagi et al.
REDOX REPORT (2002)
Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages
A Von Knethen et al.
FASEB JOURNAL (2001)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
Share Paper
